Latest News
September 11, 2017

ESSA PHARMA ANNOUNCES RESULTS FROM THE PHASE 1 CLINICAL TRIAL OF EPI-506 FOR TREATMENT OF mCRPC AND UPDATES CLINICAL AND STRATEGIC PLANS

September 07, 2017

ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress

September 01, 2017

ESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference

search-icon minus plus blue-dwn-arrow blue-right-arrow white-right-arrow white-right-arrows seffron-dwn-arrow seffron-up-arrow play-btn gray-left-arrow gray-right-arrow
error: Right click disabled